Skip to content
RDL Network logo
Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy — Masatoshi Kudo (2023) | RDL Network